US20120058983A1 - Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension - Google Patents

Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension Download PDF

Info

Publication number
US20120058983A1
US20120058983A1 US13/210,889 US201113210889A US2012058983A1 US 20120058983 A1 US20120058983 A1 US 20120058983A1 US 201113210889 A US201113210889 A US 201113210889A US 2012058983 A1 US2012058983 A1 US 2012058983A1
Authority
US
United States
Prior art keywords
yl
hydrogen
methyl
ethyl
sulfanyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/210,889
Inventor
Jürgen Klar
Georges von Degenfeld
Hans-Georg Lerchen
Barbara Albrecht-Küpper
Andreas Knorr
Peter Sandner
Daniel Meibom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP10175151 priority Critical
Priority to EP10175151.9 priority
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of US20120058983A1 publication Critical patent/US20120058983A1/en
Application status is Abandoned legal-status Critical

Links